Jazz Pharmaceuticals plc — Director's Dealing 2023

Mar 10, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2023-03-07

Reporting Person: O'Keefe Kenneth W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-03-07	Ordinary Shares	M	4500	$81.76	Acquired	25579	Direct
2023-03-07	Ordinary Shares	S	2690	$138.3894	Disposed	22889	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-03-07	Non-Qualified Stock Option (right to buy)	$81.76	M	4500	Disposed	2013-08-07	Ordinary Shares (4500)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	4445	Indirect

Footnotes

F1: Shares sold to pay option price from the exercise of stock options.

F2: Shares are held for the benefit of The Kenneth W. O'Keefe Trust U/A/D 2/12/1997, of which the reporting person is both trustee and beneficiary.

F3: This option was granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Option Plan. This option vested in 12 equal monthly installments beginning on September 1, 2013.